跳至主要内容
临床试验/NCT05574179
NCT05574179尚未招募早期 1 期

Comparison of Sedative Effect of Dexmedetomidine and Midazolam for TIVA in Pediatric Population Undergoing Inguinal Hernia Repair, Randomized Controlled Trial

Sheikh Zayed Medical College0 个研究点目标入组 60 人开始时间: 2023年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
尚未招募
入组人数
60
主要终点
Dexmedetomidine is better sedative agent than midazolam in pediatric population

研究概览

简要总结

Comparison of sedative effects of dexmedetomidine and midazolam using ramsay sedation scores intraoperatively in children undergoing inguinal hernia repair.

详细描述

a randomized controlled trial to compare the sesative effects of dexmedetomidine and midazolam in pediatric population planned for inguinal herna repair under TIVA in sheikh zayed hospital rahim yar khan.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Participant)

入排标准

年龄范围
6 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • ASA I and II Age 6 to 12 years Any gender

排除标准

  • ASA III and above Age less than 2 years and above 12 years Congenital heart disease Cardiac arrythmias Congenital abnormalities Respiratory disease Endocrine disorders Mental retardation Organ dysfunction Bleeding disorders Physician or family refusal Previous surgeries Allergy to any drug

研究组 & 干预措施

midazola.

Experimental

Inj.midazolam

干预措施: Midazolam (Drug)

Dexnedetomidine

Experimental

inj.dexmedetomidine

干预措施: Dexmedetomidine injection (Drug)

结局指标

主要结局

Dexmedetomidine is better sedative agent than midazolam in pediatric population

时间窗: 25 minutes

次要结局

  • Midazolam is better sedating agent than dexmedetomidine in pediatric population(25 minutes)
  • Midazolam and dexmedetomidine are equally good sedating agents in pediatric population(25 minutes)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Barzah Durrani

Dr Barzah durrani

Sheikh Zayed Medical College

相似试验